MONTREAL, QUEBEC--(CCNMatthews - Nov. 8, 2005) - Mistral Pharma Inc. (TSX VENTURE:MIP) announced today that the US Patent Office has granted a patent (US # 6,960,357) for its SAVIT drug delivery technology. Mistral’s SAVIT technology is licensed from Savit Consulting Inc., a company held by Dr. Sham Chopra, inventor of the SAVIT technology and Mistral’s Chief Scientific Officer.